top of page


Prevention as a Service

In 2015, we realized that nearly every available Diabetes healthcare tool was focused on treatment— not prevention. Bio Conscious was born of a need to do things differently. It was clear to us that modern medicine had not kept up with modern technology. Now, using the power of intelligent algorithms, we are changing the way the world understands and manages chronic conditions, including Diabetes,  by focusing on disease prevention.


Our first product, Diabits, demonstrated the power of foresight. It proved that we can transform Diabetes care and management by looking forward, not backward. 


In 2019 we unveiled Endobits – the evolution of forward-looking decision-support. More powerful and significantly advanced from the original, Endobits has been proven in clinical pilots and proven to help patients increase time in range daily, improve their glucose variability up to 20%, and drop their HbA1c by 1%. (


Leading the way with machine learning 

Our methodology is based on machine learning technology. Our algorithms are able to analyze and model metabolic behavior in order to better calculate the most probable future metabolic outcome.


Glucose metabolism and helping patients manage diabetes has been our core focus—but this technology is applicable to conditions ranging from heart disease to hypertension, dementia, and so much more.


We’re striving to create a symphony of algorithms that work together to provide users with a complete picture of their overall health along with specific and actionable insights that help them live healthier for longer.

Core values



your user's shoes



the big picture






your team

Join our team 

We are looking for smart and talented people that are passionate about changing the way we think about healthcare.

The Executive Team

Amir Hayeri, M.Sc., Founder and CEO

Amir has a diverse background in developing novel medical software technology. Using machine learning technology, Amir developed a novel technology to anticipate and prevent chronic disease complications. Amir has presented this technology at the 78th, 79th, and 80th, American Diabetes Association Scientific summits and is actively contributing to the science of glucose monitoring and how it can anticipate and prevent glucose-based conditions for patients with diabetes. 

Neil Clegg - COO

Neil has over 40 years of experience in the public and private sectors and the Canadian Forces.  Following retirement from the Department of Foreign Affairs and International Trade in 2011, Neil joined Platinum Group Metals Limited, a Canada-China-South Africa Joint Venture developing platinum mines in South Africa. Since leaving Platinum Group in 2015, Neil has served in senior executive capacities in the mining, investment prospecting, and pharmaceutical industries. In November 2019, he was appointed Chief Executive Officer of Libang Capital (Canada) Limited, a Xian Libang Pharmaceutical Company Limited subsidiary. In June 2022, Neil joined Bio Conscious Technologies Inc. 

Keith Burke, MSc - CTO

With 15 years of tech experience in Europe and Australia, Keith came to Bio Conscious in 2019. Keith received his Masters’s Degree in 2016 for his study on Educational Games for Adults with Intellectual Disabilities. With an award-winning Pilot Study from the European Conference for Games-Based Learning, our incredibly focused, talented, and humble CTO is determined to make Bio Conscious a global industry leader in not only Diabetes Care but Health Care as a whole. 

Pardiss Danaei, MASc - Director of Machine Learning 

Pardiss joined Bio Conscious in January 2021. With an MASc in Biomedical Engineering, specializing in Machine Learning, she has worked directly with physicians to develop Deep Learning models and  tailored solutions to assist diagnostic processes.

Directors & Advisors

Bio Conscious medical and scientific advisors are highly respected thought leaders in their industry. Our advisors have a deep understanding of our technology. We have chosen our advisors for their industry expertise and guidance  in clinical use as it applies to our technology. 

Telfer Hanson - Executive Chairman of the Board

Telfer is an experienced capital markets and investment banking professional, having served 22 years in senior investment banking positions. Since 2017, Mr. Hanson has been Chairman and/or Founder of a number of private and public companies, in the Life Sciences and Consumer Products space.

Jerome Fischer, MD, Endocrinologist - Scientific Advisor

Dr. Fischer received his B.A. in Biology from the University of Pennsylvania and his M.D. from the Jefferson Medical College of Thomas Jefferson University. He has over 30 years of experience as an endocrinologist and in the medical device industry, specializing in diabetes care and healthcare delivery. 

Christine Voss, Ph.D. - Scientific Advisor

Dr. Voss received her B.Sc. in Biochemistry from the University of London. She received her M.Sc. in Sports Sciences from Brunel University and earned her Ph.D. in Sports and Exercise Science at the University of Essex.


Head Office

550 Robson St. -3rd Floor

Vancouver, BC   V6B 2B7


bottom of page